Drug intelligence / Profile preview

jiuwei yongan tang granules

Development stage: Unknown
Lead developer: Shanghai Changhai Hospital
Administration: Oral

Overview

Jiuwei Yongan Tang granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by Shanghai Changhai Hospital for the treatment of atopic dermatitis, specifically targeting the 'Blood Deficiency and Wind Dryness' syndrome. The name 'Jiuwei' indicates the formula is composed of nine herbal ingredients, while 'Yongan' refers to the specific decoction name. It is designed to nourish blood, moisten dryness, and dispel 'wind' to alleviate skin lesion severity and pruritus (itching). In clinical trials, it has been evaluated in randomized, parallel-group studies against standard antihistamines like cetirizine (Xianteming) in patients aged 12 to 65 years.

Other names: Jiuwei Yongan DecoctionJiuwei Yongan Tang九味永安汤

Beyond the preview

Go deeper on jiuwei yongan tang granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jiuwei yongan tang granules.

Explore the full profile